Call for postdocs in Cancer Therapeutic resistance
If you are looking for a postdoc, keep reading!
The Catalan Institute of Oncology is looking for highly motivated early career scientists with potential to win a 2-years contract “Beatriu de Pinós” postdoctoral fellowship funded by the Catalan Government.
The candidate will develop and lead his/her own research withinthe focus areas of one of the 10 different research groups at ProCURE, which have produced high-quality science in the following topics across major cancer types:
- Cancer development
- Metabolic stemness
- Patient-derived xenografts
- Stroma-tumor interaction
- Cancer genetics.
Candidates must meet the following requirements:
a) They must have obtained their doctorate between 1 January 2009 and 31 December 2014 (the period for obtaining the doctorate can be from 1 January 2007 to 31 December 2014 if any of the following circumstances can be demonstrated as arising during said period: have benefitted from a period of maternity or paternity leave; have been responsible for children under six, persons with a physical or mental disability or sensory impairment, or persons aged over sixty-five who depend upon the beneficiary and who require special care; have suffered a serious illness or an accident resulting in medical leave of more than six months).
b) Have, at the time of joining the host institute, a minimum of 2 years’ postdoctoral experience outside of Spain. This postdoctoral experience may, irrespective of the type of contract, have occurred in different institutions, provided that the total postdoctoral stay/visit is of at least two years.
c) They must not have resided or worked in Spain for more than 12 months in the three years prior to date of submission of the application.
To apply, please send a cover letter containing a statement of research interest and experience (pdf), a CV (pdf) and names and contact information for 2 REFERENCES that are familiar with you and with your work to: firstname.lastname@example.org ; procureICO@gmail.com.
Deadline on 10 November.